These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Hospitalisation associated with use of the synthetic cannabinoid K2. Glue P; Al-Shaqsi S; Hancock D; Gale C; Strong B; Schep L N Z Med J; 2013 Jun; 126(1377):18-23. PubMed ID: 23831873 [TBL] [Abstract][Full Text] [Related]
25. [Short-and long-term effects of cannabinoids on memory, cognition and mental illness]. Sagie S; Eliasi Y; Livneh I; Bart Y; Monovich E Harefuah; 2013 Dec; 152(12):737-41, 751. PubMed ID: 24483000 [TBL] [Abstract][Full Text] [Related]
26. The impact of changes in UK classification of the synthetic cannabinoid receptor agonists in 'Spice'. Dargan PI; Hudson S; Ramsey J; Wood DM Int J Drug Policy; 2011 Jul; 22(4):274-7. PubMed ID: 21482092 [TBL] [Abstract][Full Text] [Related]
27. It's All in the Rhythm: The Role of Cannabinoids in Neural Oscillations and Psychosis. Skosnik PD; Cortes-Briones JA; Hajós M Biol Psychiatry; 2016 Apr; 79(7):568-77. PubMed ID: 26850792 [TBL] [Abstract][Full Text] [Related]
28. Corrigendum to "Thoracic spinal arteriovenous malformation in a 16-year-old presenting with headache" [Am J Emerg Med. 2022 Jun;56:396.e5-396.e8. Epub 2022 Apr 1]. Schoonover A; Nanda S; Singer J; Benner C Am J Emerg Med; 2022 Sep; 59():220. PubMed ID: 35835656 [No Abstract] [Full Text] [Related]
29. Prevalence of Rhabdomyolysis in Sympathomimetic Toxicity: a Comparison of Stimulants. O'Connor AD; Padilla-Jones A; Gerkin RD; Levine M J Med Toxicol; 2015 Jun; 11(2):195-200. PubMed ID: 25468315 [TBL] [Abstract][Full Text] [Related]
31. The role of mitochondrial uncoupling in 3,4-methylenedioxymethamphetamine-mediated skeletal muscle hyperthermia and rhabdomyolysis. Rusyniak DE; Tandy SL; Hekmatyar SK; Mills E; Smith DJ; Bansal N; MacLellan D; Harper ME; Sprague JE J Pharmacol Exp Ther; 2005 May; 313(2):629-39. PubMed ID: 15644431 [TBL] [Abstract][Full Text] [Related]
32. Severe rhabdomyolysis as a consequence of the interaction of fusidic acid and atorvastatin. Magee CN; Medani SA; Leavey SF; Conlon PJ; Clarkson MR Am J Kidney Dis; 2010 Nov; 56(5):e11-5. PubMed ID: 20888103 [TBL] [Abstract][Full Text] [Related]
33. Guidance is needed on synthetic cannabinoid receptor agonists and cannabis. Hamilton I BMJ; 2016 Jun; 353():i3491. PubMed ID: 27353736 [No Abstract] [Full Text] [Related]
35. Psychosis associated with synthetic cannabinoid agonists: a case series. Hurst D; Loeffler G; McLay R Am J Psychiatry; 2011 Oct; 168(10):1119. PubMed ID: 21969050 [No Abstract] [Full Text] [Related]
36. Global incidence of rhabdomyolysis after cooked seafood consumption (Haff disease). Diaz JH Clin Toxicol (Phila); 2015 Jun; 53(5):421-6. PubMed ID: 25789572 [TBL] [Abstract][Full Text] [Related]
37. [A case of the complications following glycerin enema which suggested malignant hyperthermia]. Maeda E; Mori Y; Amano E; Akamatsu T; Okada T Masui; 2010 Jul; 59(7):914-7. PubMed ID: 20662298 [TBL] [Abstract][Full Text] [Related]
38. Synthetic cannabinoid leading to cannabinoid hyperemesis syndrome. Bick BL; Szostek JH; Mangan TF Mayo Clin Proc; 2014 Aug; 89(8):1168-9. PubMed ID: 25092369 [No Abstract] [Full Text] [Related]
39. Synthetic cannabinoid intoxication: a case series and review. Harris CR; Brown A J Emerg Med; 2013 Feb; 44(2):360-6. PubMed ID: 22989695 [TBL] [Abstract][Full Text] [Related]
40. [Non-traumatic rhabdomyolysis in medical practice]. Lionte C; Sorodoc L; Petriş O; Sorodoc V; Bologa C; Anton G Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1025-33. PubMed ID: 20191869 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]